NEW APPROACHES TO DISSEMINATING TREATMENT:
|
|
- Berniece Bridges
- 5 years ago
- Views:
Transcription
1 NEW APPROACHES TO DISSEMINATING TREATMENT: TECHNOLOGY, LOW BARRIER MAT AND PRISON HEALTH Colleen T. LaBelle, MSN, RN-BC,CARN Program Director, Office-Based Addiction Treatment Director, STATE OBOT-B Boston Medical Center BU CTSI 7th Annual Translational Science Symposium May 3, 2018
2 OVERDOSE DEATHS CONTINUE TO RISE: EPIDEMIC RAPIDLY EVOLVING We are HERE: Polysubstance use the norm, rather than exception Drug supply more lethal and unpredictable Heavy focus on reducing supply = abandonment of many chronic pain patients Identifying high risk populations easier than serving them Addiction workforce must evolve in parallel to the needs of populations impacted 2
3 AN EVOLVING EPIDEMIC REQUIRES FLEXIBILITY AND INNOVATION Harm reduction approach: low threshold Treatment on demand: ED*, walk in, open access Expanding buprenorphine through mid-level providers Prescriptive authority of NPs in all states Prescriptive authority for all NPs under DATA 2000 (e.g., CNM) Interventions targeted to needs of high-risk populations Use of technology: (ECHO), Telemedicine/Telehealth, Electronic Prescribing, webbased resources 3
4 WHAT IS EVIDENCE-BASED CARED FOR OPIOID USE DISORDER? Methadone: full opioid agonist Only available in specially licensed opioid treatment programs Buprenorphine: partial opioid agonist Commonly combined with naloxone, an opioid antagonist (to deter injection) Use in office-based setting requires DEA waiver 8 hour training for MDs per DATA hours of training for NPs and PAs per CARA Act Naltrexone: opioid antagonist Use in office-based setting without special certification Evidence of efficacy in specific populations Overall efficacy not well established NIDA (2012). Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition). SAMSHA (2015). Federal Guidelines for Opioid Treatment Programs. HHS Publication No. (SMA) PEP15-FEDGUIDEOTP. Kampman & Jarvis (2015). American Society of Addiction Medicine (ASAM) National Practice Guideline for the use of medications in the treatment of addiction involving opioid use. Journal of addiction medicine, 9(5),
5 VALUE OF MEDICATION FOR ADDICTION TREATMENT (MAT) Medicaid medical costs decreased by 33 % over 3 years following engagement in treatment Decline in expenditures: hospitals, emergency departments, and outpatient services Baltimore study 50% decrease mortality with buprenorphine and methadone treatment Overdose deaths ED and hospital admissions Medical costs Massachusetts decrease ED, and hospital admissions with retention in treatment Alford DP, LaBelle CT, Kretsch N, et al. Arch Int Med. 2011;171: Walter, L. et al (2006). Medicaid Chemical Dependency Patients in a Commercial Health Plan, Robert Wood Johnson Foundation, Princeton, New Jersey Schwartz et al. American Journal of Public Health. 2013; 103(5): Medication for addiction treatment 5
6 RAPIDLY EXPAND MODELS PROVEN TO INCREASE ACCESS TO MAT 6
7 THE BMC NURSE CARE MANAGER (AKA MASSACHUSETTS) MODEL FOR OFFICE BASED ADDICTION TREATMENT (OBAT) Nurse Care Managers (NCMs) increase patient access to treatment Nurses working at top of their license Efficient and effective utilization of buprenorphine-waivered prescribers NCM role includes: Case management Brief counseling, social support, patient navigation NCMs able to address Urine toxicology results Insurance issues Prescription/pharmacy issues Pregnancy, acute pain, surgery, injury Concrete service support Intensive treatment, legal/social issues, safety, housing 7
8 INCREASING ACCESSTO LIFE-SAVING MEDICATION: CREATING A NETWORK OF OBAT PROVIDERS ACROSS MASSACHUSETTS BMC OBAT TTA In 2007 State Technical Assistance Treatment Expansion (STATE) OBAT Program created to expand BMC model to 14 CHCs across MA First 5 years of outcomes: Between 2007 and 2013, 14 CHCs successfully initiated OBAT Physicians waivered increased by 375%, 24 to 114 over 3 years Annual admissions of OBAT patients to CHCs increased from 178 to 1, % of OBOT patients enrolled in FY 2013/2014 remained in treatment 10 months 8
9 STATE OBAT TRAINING AND TECHNICAL ASSISTANCE (OBAT TTA) INITIATIVE IN CHCS: PROJECT GOALS ACCESS Expand treatment & access to buprenorphine Increase number of waivered MDs Increase number of individuals treated for opioid addiction Integrate addiction treatment into primary care settings DELIVERY Effective delivery model for buprenorphine Modeled after BMC s Nurse Care Manager Program Focus on high risk areas, underserved populations SUSTAINABILITY Post-program funding Develop a long-term viable funding plan Collect & analyze outcomes data 9
10 WE HAVE SHOWN SUCCESS SCALING IN MASSACHUSETTS AND ARE NOW SHARING OUR LEARNINGS NATIONALLY We ve shown scalability in Massachusetts... Now sharing model nationally No. of sites provided OBAT TTA in last 3 years NIDA CTN-0074: Primary Care Opioid Use Disorders Treatment (PROUD) Trial Testing BMC Nurse Care Manager Model against standard of care in 6 health systems nationwide in ~10,000 patients 10
11 PAST 3 MONTH HEALTH CARE UTILIZATION OUTCOMES MA OBAT SITES JUL 1 SEP 30, 2017 (N=6,506) 16.6% % of patients in STATE OBAT Program 4.4% In treatment <= 12 mos. In treatment > 12 mos. 5.3% 1.1% 3.8% 10.9% Retention in OBAT Detox, inpatient, ED admissions 1+ night detox 1+ night inpatient hospital 1+ ED 11
12 LOWERING BARRIERS TO RECEIPT OF MEDICATIONS FOR ADDICTION TREATMENT (MAT) You need a little love in your life and some food in your stomach before you can hold still for some damn fool s lecture about how to behave Billie Holiday 12
13 Trained over 1,400 individuals at 36 state-wide trainings 13 buprenorphine waiver trainings 7 CARN Review Courses 5 Essentials of OBAT Trainings 4 Advanced Topics in Buprenorphine Practice and Beyond 3 Addiction 101Trainings 2 trainings for Early Intervention providers 1 Buprenorphine implant training 1 statewide conference REACH OF BMC OBAT TTA TEAM APR 2017 APR 2018 Provided >140 hours of on site technical assistance to >50 community OBAT sites Program responsive to changing needs of providers and patients 13
14 LOWERING THRESHOLD FOR TREATMENT IN OFFICE-BASED SETTINGS Fewer requirements for MAT in new BMC Clinical Guidelines LaBelle, C. T.; Bergeron, L. P.; Wason, K.W.; Ventura, A. S.; and Beers, D. Policy and Procedure Manual of the Office Based Addiction Treatment Program for the use of Buprenorphine and Naltrexone Formulations in the Treatment of Substance Use Disorders. Unpublished treatment manual, Boston Medical Center, Mar
15 CARA LEGISLATION: NPS AND PAS ABLE TO PRESCRIBE BUPRENORPHINE! Ultimate goal of extending outreach to non-physicians and non-addiction specialty settings NPs and Pas must obtain waiver, same as physicians As of July 2016: allowed to prescribe Requirements include: 24 hours of education in addiction 8 hours of a waiver training (maybe a part of 24hour requirement) Supervised practice by waivered provider in states with supervised practice 30 patient limit year one Maximum 100 limit can apply after year one Approval for period of time then a review by HHS 15
16 2018 WAIVERED MDS AND DOS BY STATE N = 42,015 States with Highest % of Waivered MDs/DOs* Vermont = 14.1% Maine = 12.6% Alaska = 10.2% New Mexico = 9.3% VT = 307 NH = 292 CT = 832 MA = 2339 RI = 369 NJ = 1307 DE = 136 MD = 1233 DC = 158 Rhode Island = 7.8% *Not including U.S. Territories 185 HI = 159 GU = 2 MP = 1 PR = 528 VI = 2 16
17 2018 WAIVERED NURSE PRACTITIONERS BY STATE N=5,284 States with Highest % of Waivered NPs Vermont = 11.3% Maine = 10.8% New Mexico = 9.6% VT = 42 NH = 87 MA = 306 RI = 47 CT = 182 NJ = 150 DE = 25 DC = 30 MD = 282 New Hampshire = 8.5% Maryland = 8.5% 36 PR = 0 GU = 0 MP = 0 VI = 0 HI = 20 17
18 2018 WAIVERED PHYSICIAN ASSISTANTS BY STATE N = 1,389 States with Highest % of Waivered PAs Alaska = 5.6% Utah = 4.4% Washington = 4.4% Rhode Island = 4.2% Vermont = 4.0% HI = 2 19 VT = 10 RI = 13 NH = 10 MA = 69 CT = 23 NJ = 17 DE = 7 MD = 50 DC = 4 GU = 0 MP = 0 PR = 0 VI = 0 18
19 NO. OF MDS, NPS AND PAS THAT COMPLETED 8 HOUR BUPRENORPHINE WAIVER TRAINING APR APR MDs 138 NPs 94 No. completing waiver training PAs 26 MDs Nurse Practitioners Physicians Assistants BMC OBAT TTA continues to dedicate resources to engage mid-level providers to meet requirements to prescribe buprenorphine 1 9
20 EVIDENCE OF COMPARABLE CARE NP VS. MD Evidence for Quality Improvement, high quality care Similar patient outcomes to physician-provided care Patients report high levels of satisfaction. NPs can address shortfall of primary care providers Empowering NPs to diagnose and prescribe without physician oversight is important to ensuring there is an adequate primary care workforce to serve this new population NPs are more likely than MDs to treat patients in settings where provider resources are scarce McCleery et al. Evidence Brief: The Quality of Care Provided by Advanced Practice Nurses Sep. In: VA Evidence-based Synthesis Program Evidence Briefs [Internet]. Washington (DC): Department of Veterans Affairs (US);
21 TAILORING SERVICES TO HIGH RISK POPULATIONS: A FOCUS ON POST-INCARCERATION 21
22 Risk of opioid overdose death following incarceration is 56x higher than for the general public Risk is greatest during first following release Of those incarcerated, young people (18-24) are 10x more likely to die than those >45 An Assessment of Opioid-Related Deaths in Massachusetts ( ). MA Department of Public Health. September Accessed at: file:///c:/users/alventu1/downloads/dph-legislative-report-chapter-55-opioid-overdose-study pdf 22
23 ENGAGING INCARCERATED PERSONS AT TIME OF RELEASE: BMC Partnership with South Bay House of Corrections Services advertised throughout HOC for people with SUD Providers present inside HOC during community meetings on services offered by BMC s OBAT Clinic For those interested, providers meet with people incarcerated inside the HOC Establishes relationship Documentation of substance use history Medical clearance Aim: direct linkage upon release Clinic will accept and prioritize post-release walk-ins during all clinic hours Partnerships with other jails/prisons in place OBAT S PARC CLINIC 23
24 TECHNOLOGY AS A TOOL FOR WORKFORCE DEVELOPMENT 24
25 Between Apr 2017 and Apr ,222 unique individuals have visited OBAT TTA website (bmcobat.org) 16,293 total sessions 74,012 total page views OBAT TTA website visitors from: 58 countries 49/50 of States 222 unique municipalities across Massachusetts LEVERAGING TECHNOLOGY: OBAT TTA WEBSITE AND RESOURCES 25
26 LEVERAGING TECHNOLOGY: ADDICTION ECHO (EXTENSION FOR COMMUNITY HEALTHCARE OUTCOMES) HUBS AT BMC Using teleconferencing technology, primary care providers connect to other learners and expert Hub teams Hub and spoke model increases access to specialty care Two main components of all teleecho clinic: 1. Brief didactic presentation 2. Case-based learning ( pt. case by spoke participant) Community providers learn from specialists Community providers learn from each other Specialists learn from community providers as best practices emerge 26
27 REACH OF BMC S ADDICTION ECHO HUBS National Opioid Addiction Treatment ECHO A national collaboration between the ECHO Institute, HRSA, the American Society of Addiction Medicine (ASAM), and 5 expert addiction hubs Mass Office Based Addiction Treatment (OBAT) ECHO OBAT ECHO is for Mass cites implementing office based addiction treatment, funded by Opioid STR 27
28 OVERVIEW OF BMC S OBAT (OBAT TTA) PROGRAM Statewide Waiver Trainings Other statewide addiction trainings (e.g., Essentials of OBAT) On-site technical assistance provided by expert consultant OBAT TTA Website Addiction Hotline National and State-specific Guidelines for NCM OBAT model National Opioid Addiction Treatment ECHO MA Office Based Addiction Treatment ECHO Addiction provider list server 28
29 Flexibility AN EVOLVING EPIDEMIC REQUIRES Responsive to current and changing needs Change Agents Innovation Nurses will continue to play key role in addressing the current epidemic of addiction and overdose deaths. 29
30 Remove scope-of-practice barriers. Advanced practice registered nurses should be able to practice to the full extent of their education and training Increase the proportion of nurses with a baccalaureate degree to 80 percent by 2020 Ensure that nurses engage in lifelong learning Nurses should be full partners with physicians and other health professionals, in redesigning health care in the United States Prepare and enable nurses to lead change to advance health Committee on the Robert Wood Johnson Foundation Initiative on the Future of Nursing, at the Institute of Medicine. (2011). 30
31 QUESTIONS? 31
CURRENT U.S. OPIOID EPIDEMIC 9/25/2018 LEVERAGING NURSES TO EXPAND ACCESS TO TREATMENT IN THE OPIOID EPIDEMIC DISCLOSURES
LEVERAGING NURSES TO EXPAND ACCESS TO TREATMENT IN THE OPIOID EPIDEMIC DISCLOSURES I have no personal or financial conflicts of interest to disclose Colleen LaBelle MSN, RN-BC, CARN Directors STATE Office-Based
More informationSC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC
SC MAT ACCESS Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC Overdose Death Rates from Opiates Most important sign of a
More informationNurse Care Managers Treating Opioid Use Disorder
Nurse Care Managers Treating Opioid Use Disorder Colleen T. LaBelle, MSN, RN-BC,CARN Program Director, Office-Based Addiction Treatment Director, STATE OBOT-B Boston Medical Center Disclosures I have no
More informationTREATING OPIOID ADDICTION IN HOMELESS POPULATIONS
TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS Challenges and Opportunities Providing Medication Assisted Treatment (Buprenorphine) August 18, 2016 SPEAKERS TODAY Nilesh Kalyanaraman, MD, Chief Health
More informationQUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.
2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted
More informationAddressing the Opioid Crisis Policy Recommendations
Addressing the Opioid Crisis Policy Recommendations The Pew Charitable Trusts Pew is an independent nonprofit, nonpartisan research and policy organization. Tools: Research Partnerships Technical assistance
More informationDisclosures. I have no disclosures or commercial interests to report
Colleen T. LaBelle, MSN, RN-BC,CARN Program Director, Office-Based Addiction Treatment Director, STATE OBAT Boston Medical Center Disclosures I have no disclosures or commercial interests to report Medication-Assisted
More informationOUD & MAR: Caring for Our Communities
OUD & MAR: Caring for Our Communities Speaker: Elisabeth Fowlie Mock, MD, MPH Video Resources Diversion Alert/recoveryinme video https://www.youtube.com/watch?v=q1lsmwwwm40 CDC Videos RX Awareness Campaign
More informationPERSPECTIVE FROM VIRGINIA: SUCCESS ADDRESSING THE OPIOID CRISIS THROUGH MEDICAID ADDICTION AND RECOVERY TREATMENT SERVICES (ARTS)
PERSPECTIVE FROM VIRGINIA: SUCCESS ADDRESSING THE OPIOID CRISIS THROUGH MEDICAID ADDICTION AND RECOVERY TREATMENT SERVICES (ARTS) Katherine Neuhausen, MD, MPH, Chief Medical Officer Virginia Department
More informationBeacon Health Options Project ECHO - Opioid Use Disorders. Program Description and Application for Participation
Beacon Health Options Project ECHO - Opioid Use Disorders Program Description and Application for Participation Update 2-20-18 for Continuous Enrollment Purpose Application PROJECT ECHO (Extension for
More informationAddressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention
The Accountable Community for Health of King County Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention May 7, 2018 1 Opiate Treatment & Overdose Prevention Project Goal Immediate:
More informationRI Centers of Excellence for the
RI Centers of Excellence for the Treatment of Opioid Use Disorder COE CODAC Behavioral Healthcare Linda Hurley President/CEO 9-18-17 for the Warren Alpert Medical School of Brown University RI s Strategic
More informationManagement Options for Opioid Dependence:
Management Options for Opioid Dependence: Policy Implications and Recommendations Dan Ollendorf, PhD Sarah Jane Reed, MSc New England CEPAC Goal: To improve the application of evidence to guide practice
More informationState Opioid Response (SOR) Grant
State Opioid Response (SOR) Grant Adam Bucon, LSW DMHAS Provider Meeting September 20, 2018 Philip D. Murphy Governor Shereef M. Elnahal Commissioner Sheila Y. Oliver Lt. Governor NJ Opioid Statistics
More informationAgenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model
Agenda 1 Opioid Addiction in the United States 2 Evidence-based treatments for OUD OUD Treatment: Best Practices 4 Groups: Our Model 2 Groups is a national network of clinics providing affordable, evidencebased
More informationManagement of Opioid Use Disorder in Primary Care
1 Northwest ATTC presents Management of Opioid Use Disorder in Primary Care Joseph O. Merrill, MD, MPH University of Washington Associate Professor of Medicine 4/26/2018 Today s Presenter 2 Joseph Merrill,
More informationKentucky s Plan to Address the Opioid Crisis National Statistics. Scope of the Problem 3/14/18
Kentucky s Plan to Address the Opioid Crisis Dr. Katherine Marks Critical Access Hospital Substance Abuse Summit March 8, 2018 2016 National Statistics Deaths per 100,000 population 25 20 15 10 5 Scope
More informationThe Care Alliance for Opioid Dependence
The Care Alliance for Opioid Dependence The Vermont Hub and Spoke Model John Brooklyn, MD Clinical Assistant Professor of Family Practice and Psychiatry University of Vermont College of Medicine Medical
More informationDivision of Mental Health and Addiction Services
Division of Mental Health and Addiction Services A DAM BUCON, LSW DMHAS Mission DMHAS, in partnership with consumers, family members, providers and other stakeholders, promotes wellness and recovery for
More informationBuprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction
Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction The Problem The overdose death rate in Missouri and in the country has been rising for
More informationMGH Substance Use Disorder Initiative. Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP MGH ED Christopher Shaw, RN, ANP, PMHNP-BC, CARN-AP MGH ACT
Bridging the Gap: Bridging the Gaps to addiction treatment through comprehensive collaborative practice among Advanced Practice Nurses in a large urban Medical Center Dawn Williamson, RN, DNP, PMHCNS-BC,
More informationNew Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS
New Initiatives to Expand Access to Medication Assisted Treatment in NYS OASAS Charles W. Morgan, MD, DFASAM, FAAFP Medical Director New York State Office of Alcoholism and Substance Abuse Services February
More informationKentucky s Strategic Action Plan. Katherine Marks, Ph.D. August 16, 2018
Kentucky s Strategic Action Plan Katherine Marks, Ph.D. August 16, 2018 OUTLINE The state & the need The organization of a response The action plan THE STATE AND THE NEED KENTUCKY 4.4 million people 35
More informationFrom Medicaid Transformation Approved Project Toolkit, June 2017
From Medicaid Transformation Approved Project Toolkit, June 2017 Domain 3: Prevention and Health Promotion Transformation projects within this domain focus on prevention and health promotion to eliminate
More informationProgress Report and 2018 Legislative Opportunities. Maine Opiate Collaborative Recommendations
Progress Report and 2018 Legislative Opportunities related to the Maine Opiate Collaborative Recommendations April 2018 A. Destigmatize substance use disorders within the law enforcement profession 1.
More informationPublic Health Federal Funding Request to Address the Opioid Epidemic
Public Health Federal Funding Request to Address the Opioid Epidemic On December 4, 2017, in response to the President s recent declaration of the opioid epidemic as a public health emergency and the final
More informationHospitals Role in Addressing the Opioid Crisis
Hospitals Role in Addressing the Opioid Crisis Webinar 5: Buprenorphine in the Emergency Department November 14, 2017 Agenda Hospital Based Buprenorphine Initiatives Yngvild Olsen, M.D., Medical Consultant,
More informationOpioid Best Practices
Prevention Partnerships, collaboration and coalition building Focus on youth, adolescent and young adult messaging and services Public information and media campaigns: prevention, education and awareness
More informationAn Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder
An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder CONTENTS I. Need for an Alternative Payment Model for Opioid Use Disorder and Addiction... 2 A. Improving Services
More informationADDRESSING THE OPIOID EPIDEMIC. Joint principles of the following organizations representing front-line physicians
ADDRESSING THE OPIOID EPIDEMIC Joint principles of the following organizations representing front-line physicians American Academy of Family Physicians American Academy of Pediatrics American College of
More informationKurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center
Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States
More informationMETHADONE TO BUPRENORPHINE TRANSFERS TRANSITIONING FROM METHADONE MAINTENANCE TO BUPRENORPHINE/NALOXONE
METHADONE TO BUPRENORPHINE TRANSFERS TRANSITIONING FROM METHADONE MAINTENANCE TO BUPRENORPHINE/NALOXONE Work with methadone clinic staff to coordinate the methadone taper, with the transition to buprenorphine/naloxone:
More informationNURSING FOLLOW-UP: NALTREXONE NALTREXONE NURSING FOLLOW-UP VISIT
NURSING FOLLOW-UP: NALTREXONE Provider Name: Provider Signature: Date: NALTREXONE NURSING FOLLOW-UP VISIT Visit type: Scheduled Call-back Walk-in Random call-back Patient Receives: Oral naltrexone Extended-release
More informationSubstance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates
Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates What is MAT? Medication Assisted Treatment (MAT) is the use of medications, in addition to counseling, cognitive behavioral
More informationStatus of Opioid Treatment Efforts
Status of Opioid Treatment Efforts Health Reform Oversight Committee October 25, 2016 Harry Chen, MD, Commissioner The National Safety Council Categorized Vermont as One of Four States Making Progress
More informationSaving Lives and Treating Addiction in Baltimore City
Saving Lives and Treating Addiction in Baltimore City Mark O Brien Director of Opioid Overdose Prevention and Treatment Evan Behrle Special Assistant to the Health Commissioner Catherine E. Pugh Mayor,
More informationSTATE TARGETED RESPONSE TO THE OPIOID CRISIS (OPIOID STR)
STATE TARGETED RESPONSE TO THE OPIOID CRISIS (OPIOID STR) September 26, 2017 Kimberly A. Johnson, PhD, Director, Center for Substance Abuse Treatment, SAMHSA Donna Hillman, GPO and Opioid STR CSAT Project
More informationUR Medicine Project ECHO : Improving Access to Complex Care through Videoconferencing
UR Medicine Project ECHO : Improving Access to Complex Care through Videoconferencing Thomas V. Caprio, MD, MPH, MSHPE, CMD, HMDC, FACP, AGSF Associate Professor of Medicine/Geriatrics, Dentistry, Clinical
More information4/12/2018. Disclosure Statement of Financial Interest
Consultant/Over Prescribing Team 4/12/2018 Tennessee Chronic Pain Guidelines and Controlled Substance Efforts Symposia Linda Johnson, DNP APRN Consultant/Over Prescribing Team Disclosure Statement of Financial
More informationPerformance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)
Performance of North Carolina's System for Monitoring Prescription Drug Abuse Session Law 2015-241, Section 12F.16.(q) Report to the Joint Legislative Oversight Committee on Health and Human Services and
More informationPrepublication Requirements
Issued Prepublication Requirements The Joint Commission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the print manuals
More informationClosing the Loop in Treating Opioid Addiction:
Closing the Loop in Treating Opioid Addiction: Integrating MAT into Prison and Jail Health Systems May 9, 2018 Webinar Housekeeping All lines are muted This session will be recorded To ask a question:
More informationMedicaid s Role in Combating the Opioid Crisis
1 Medicaid s Role in Combating the Opioid Crisis September 23, 2016 Deborah Bachrach Partner Manatt Health Assessing Innovations in Medicaid 1 Medicaid Started as Adjunct to Welfare Programs 2 Eligibility
More informationNURSING FOLLOW-UP: BUPRENORPHINE/NALOXONE BUPRENORPHINE/NALOXONE CLINIC VISITS
Provider Name: NURSING FOLLOW-UP: BUPRENORPHINE/NALOXONE Provider Signature: Date: BUPRENORPHINE/NALOXONE CLINIC VISITS Once stable, schedule clinic visits every 2 to 4 weeks, with refills that coincide
More informationColleen T. LaBelle, MSN, RN-BC,CARN Program Director, Office-Based Addiction Treatment Director, STATE OBAT Boston Medical Center
Colleen T. LaBelle, MSN, RN-BC,CARN Program Director, Office-Based Addiction Treatment Director, STATE OBAT Boston Medical Center Disclosures I have no disclosures or commercial interests to report Addiction
More informationEI Leadership April 24, 2018
Early Childhood Community Partnerships to Support Families Struggling with SUD EI Leadership April 24, 2018 Setting the Stage The issue of young children impacted by substance use disorders in families
More information8/16/2018. California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives. Agenda. No Wrong Door
California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives Gloria Miele, PhD, Learning Collaborative Coordinator, Hub and Spoke MAT Expansion Project Richard Rawson, PhD, Professor
More informationOpioid Use Disorder Treatment Initiation in Diverse Settings
Opioid Use Disorder Treatment Initiation in Diverse Settings Sarah Wakeman, MD, FASAM Medical Director, Mass General Substance Use Disorder Initiative Assistant Professor, Harvard Medical School Disclosures
More informationPublic Policy Statement on the Regulation of Office-Based Opioid Treatment
Public Policy Statement on the Regulation of Office-Based Opioid Treatment Background Office-based opioid treatment (OBOT) commonly refers to outpatient treatment services provided outside of licensed
More informationSAMHSA/HHS: An Update on the Opioid Crisis
SAMHSA/HHS: An Update on the Opioid Crisis Elinore F. McCance-Katz, MD, PhD Assistant Secretary for Mental Health and Substance Use Substance Abuse and Mental Health Services Administration U.S. Department
More informationThe State of Substance Misuse and Addiction: Secondary Prevention Strategies. June 1, :00 pm 3:00 pm ET Audio: ;
The State of Substance Misuse and Addiction: Secondary Prevention Strategies June 1, 2017 2:00 pm 3:00 pm ET Audio: 888-378-4398; 555512 Dr. Jay Butler, MD, CPE Chief Medical Officer Alaska Department
More informationWorking with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.
Working with People Who Use Drugs in HIV Care Settings August 29, 2017 Workshop C 2:00 3:30 p.m. Working with People Who Use Drugs in HIV Care Settings Facilitator: Liz Hall, CDPH Office of AIDS Matt Curtis,
More informationNew Jersey Mental Health and Addiction Providers Meeting April 26, Shereef Elnahal, M.D., M.B.A. Commissioner New Jersey Department of Health
New Jersey Mental Health and Addiction Providers Meeting April 26, 2018 Shereef Elnahal, M.D., M.B.A. Commissioner New Jersey Department of Health DOH Healthcare & Public Health Priorities Reduce disparities
More informationMedication Treatment and Opioid Use Disorder
Medication Treatment and Opioid Use Disorder Colleen T. LaBelle, MSN, RN-BC,CARN Program Director, Office-Based Addiction Treatment Director, STATE OBOT-B Boston Medical Center Disclosures I have no disclosures
More informationTHA Medication Safety Summit. Wesley Geminn, PharmD, BCPP
THA Medication Safety Summit Wesley Geminn, PharmD, BCPP Current Trends: Overdose Deaths in 2017 72,000 Or 197 per day 8 per hour National Opioid Overdose Statistics https://www.drugabuse.gov/related-topics/trendsstatistics/overdose-death-rates
More informationADDING EVEN MORE SUBSTANCE TO MANAGED CARE
HEALTH WEALTH CAREER ADDING EVEN MORE SUBSTANCE TO MANAGED CARE OPTIMIZING MEDICAID TO RESPOND TO SUBSTANCE USE DISORDERS NATIONAL ACADEMY FOR STATE HEALTH POLICY 30TH ANNUAL STATE HEALTH POLICY CONFERENCE
More informationIntroduction to UNC Medication Assisted Treatment (MAT) ECHO Clinic. Robyn Jordan, MD, PhD
Introduction to UNC Medication Assisted Treatment (MAT) ECHO Clinic Robyn Jordan, MD, PhD Conflicts UNC Extension for Community Healthcare Outcomes for Medication Assisted Treatment (UNC ECHO for MAT)
More informationLinking Opioid Treatment in Primary Care. Roxanne Lewin M.D.
Roxanne Lewin M.D. The Facts Fewer than 10 percent of individuals with an alcohol use disorder and only about 20 percent of individuals with an opioid use disorder receive specialty treatment. Many individuals
More informationOffice Based Addiction Treatment (OBAT) at Lowell Community Health Center. Shaun Farraher, MD Melanie Priestly, Director May 2018
Office Based Addiction Treatment (OBAT) at Lowell Community Health Center Shaun Farraher, MD Melanie Priestly, Director May 2018 Lowell CHC OBAT Program Snapshot Number of current active patients: 225
More informationThe Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016
The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine March 10, 2016 Objectives Review current state of opioid crisis in Maine Briefly review physiology of
More informationMedication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc.
Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Elements Behavioral Health Diplomate, American Board of Addiction
More informationSubmitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis
STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite
More informationGovernor Raimondo s Task Force on Overdose Prevention and Intervention May 9, 2018
Governor Raimondo s Task Force on Overdose Prevention and Intervention May 9, 2018 DIRECTOR NICOLE ALEXANDER-SCOTT, MD, MPH, RHODE ISLAND DEPARTMENT OF HEALTH DIRECTOR REBECCA BOSS, MA, RHODE ISLAND DEPARTMENT
More informationProgress Report Maine Opiate Collaborative Recommendations. on the. October 2018
Progress Report on the 2016 Maine Opiate Collaborative Recommendations October 2018 MAINE OPIATE COLLABORATIVE PROGRESS REPORT Prevention & Harm Reduction October 2018 RECOMMENDATIONS STRATEGIES 2018 LEGISLATIVE
More informationHHSC LAR Request. Substance Abuse Disorder Coalition. Contact Person: Will Francis Members:
HHSC LAR Request Substance Abuse Disorder Coalition Contact Person: Will Francis wfrancis.naswtx@socialworkers.org Members: NAMI Texas Children s Defense Fund Texas Communities for Recovery National Association
More informationVIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC
1 VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC Virginia Association of Counties November 14, 2016 The Honorable William A. Hazel, Jr., M.D. Secretary of Health and Human Resources 1999 - Estimated drug
More informationBuprenorphine Prescribing as a Patient- Centered Medical Home Enhancement
Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement TANNER NISSLY DO, BOB LEVY MD FASAM, MICHELE MANDRICH MSW, CMPE AS YOU ENTER, PLEASE SET UP TO PARTICIPATE IN OUR POLL EVERYWHERE
More informationBERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County
BERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County NMPHA Annual Conference April 2, 2014 Marsha McMurray-Avila Coordinator, Bernalillo County Community
More informationThe Opioid Crisis: What Can Physicians Do About It?
The Opioid Crisis: What Can Physicians Do About It? Richard S. Schottenfeld, M.D. Professor and Chair, Department of Psychiatry and Behavioral Sciences 2018 Louis J. Kolodner Memorial Lecture Disclosures
More informationFederal-State Response to the Opioid Crisis. Session 48 February 12, 2019
Federal-State Response to the Opioid Crisis Session 48 February 12, 2019 1 Conflict of Interest Thomas Novak, Medicaid Interoperability Lead, Office Of The National Coordinator / CMS Shereef Elnahal, MD,
More informationOpportunities and Challenges for Nursing in WA State Medicaid Expansion and other New Initiatives. Session 2
Opportunities and Challenges for Nursing in WA State Medicaid Expansion and other New Initiatives Session 2 1 Learning Objectives Learn about WA State strategies for addressing the opioid crisis, including
More informationBriefing on ARTS to Secretary Hazel October 2017
Agenda -DMAS -DBHDS -VDH -Final discussion Briefing on ARTS to Secretary Hazel October 2017 http://www.dmas.virginia.gov/ 1 Medicaid Addiction and Recovery Treatment Services (ARTS) Partial Hospitalization
More informationOPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI)
OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI) Case 105- Prep Materials University of Massachusetts Medical School Opioid Conscious Curriculum Learner Prep Objectives The purpose of this prep material
More informationThis article is protected by copyright. All rights reserved.
Re-purposing Anticoagulation Clinics: Expanding Access to Opioid Agonist Therapy in Primary Care Settings Pooja Lagisetty, MD, MSc 1,2, Michele Heisler, MD, MPA 2.3, and Amy Bohnert, PhD, MHS 3,4 1 Robert
More informationOpioid Overview Admiral Brett P. Giroir, M.D.
A S S I S TA N T S E C R E TA RY F O R H E A LT H Opioid Overview Admiral Brett P. Giroir, M.D. Assistant Secretary for Health Senior Advisor for Opioid Policy @HHS_ASH August 20, 2018 SUBSTANCE ABUSE
More informationSession IV Future Directions for Treatment for Opioid User Disorder:
Session IV Future Directions for Treatment for Opioid User Disorder: Defining Success and Identifying Outcomes that Matter Moderator: Gregory Daniel, Duke-Margolis Center for Health Policy Panelists: Alexander
More informationOpioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity
Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity Holly Hills, Ph.D. June 13, 2017 Department of Mental Health Law and Policy Overview: Persons who have not been in
More information1) To understand the scope of the opioid epidemic with relation to Emergency Departments 2) To gain insight into some emerging Emergency Medicine
1) To understand the scope of the opioid epidemic with relation to Emergency Departments 2) To gain insight into some emerging Emergency Medicine solutions to the Opioid Epidemic 3) To learn about the
More informationProject ECHO: Extending Opioid Treatment Statewide. Brian Grahan, M.D., Ph.D. Friday, Jan. 11, :20 5:20 p.m. Northland Ballroom
Project ECHO: Extending Opioid Treatment Statewide Brian Grahan, M.D., Ph.D. Friday, Jan. 11, 2019 4:20 5:20 p.m. Northland Ballroom Brian Grahan, M.D., Ph.D. Dr. Brian Grahan was introduced to addiction
More informationVermont Hub and Spoke Model Treatment Need Questionnaire
Vermont Hub and Spoke Model Treatment Need Questionnaire Friday, June 30, 2017 John Brooklyn, MD Assistant Professor of Family Medicine and Psychiatry University of Vermont Burlington, Vermont Webinar
More informationNORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Opioid Use Disorders Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 Opioid Use Disorders Importance of opioid use disorders Screening and
More informationUnderstanding and Combating the Heroin Epidemic
Understanding and Combating the Heroin Epidemic Kelly Dunn, Ph.D. Assistant Professor; Johns Hopkins School of Medicine Department of Psychiatry and Behavioral Sciences 1 Talk Outline What is causing the
More informationBUPRENORPHINE/NALOXONE THERAPY DOM CLINICAL GUIDELINES AND RECOMMENDED CHANGES
BUPRENORPHINE/NALOXONE THERAPY DOM CLINICAL GUIDELINES AND RECOMMENDED CHANGES BACKGROUND In September 2012, the Division of Medicaid (DOM) implemented criteria through electronic prior authorization (PA)
More informationMedication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs
Medication Assisted Treatment Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs Disclosures Employed by the Department of Veterans Affairs
More informationLeveraging Arizona s Medicaid Program to Drive Delivery System Innovation
Leveraging Arizona s Medicaid Program to Drive Delivery System Innovation Shelli Silver, AHCCCS Deputy Director for Health Plan Operations April 11, 2019 AHCCCS Overview AHCCCS Mission, Vision & Values
More informationSB202 MSO Community Action Plan
SB202 MSO Community Action Plan REQUEST FOR APPLICATION SIGNAL BEHAVIORAL HEALTH NETWORK 6130 GREENWOOD PLAZA BLVD, #150, GREENWOOD VILLAGE, CO 80111 MAT Expansion and Education RFA (S1-1819-MAT) 1 OVERVIEW
More informationSTATEMENT. of the. American Medical Association. for the Record. House Committee on Energy and Commerce
STATEMENT of the American Medical Association for the Record House Committee on Energy and Commerce RE: Federal Efforts to Combat the Opioid Crisis: A Status Update on CARA and Other Initiatives October
More informationChanging Course: statewide efforts to combat the opioid epidemic in California
Changing Course: statewide efforts to combat the opioid epidemic in California Kelly Pfeifer, MD kpfeifer@chcf.org April 26, 2018 State of Reform conference STAT Special Report: 52 weeks, 52 faces Obituaries
More informationLA County, Medications for Addiction Treatment, and the Substance Use Care Continuum
LA County, Medications for Addiction Treatment, and the Substance Use Care Continuum Brian Hurley, M.D., M.B.A., DFASAM Medical Director of Substance Use Related Care Integration Los Angeles County Health
More informationProviding Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont
University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2016 Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics
More informationImproving Access to Care and Treatment for Veterans through an Innovative Clinical Partnership
Improving Access to Care and Treatment for Veterans through an Innovative Clinical Partnership Lena Asmar, MSW, LICSW Director, Veteran 360 Behavioral Health Programs, New England Center and Home for Veterans
More informationA COLLABORATIVE CARE APPROACH
MASSACHUSETTS NURSE CARE MANAGER MODEL OF OFFICE BASED ADDICTION TREATMENT: CLINICAL GUIDELINES A COLLABORATIVE CARE APPROACH 2018 Boston Medical Center Updated: March 9, 2018 [Type text] Page 0 TABLE
More informationIt Takes A Village to Curb the Prescription Opioid Epidemic: Supply healthcare providers with resources to improve patient safety
Session L6 This presenter has nothing to disclose It Takes A Village to Curb the Prescription Opioid Epidemic: CDC Efforts Jan Losby, PhD Team Lead, Overdose Prevention Health Systems Team Division of
More informationSANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery
Page 1 of 9 SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery Departmental Polley and Procedure Section Sub-section Alcohol and Drug Program (ADP) Effective: 7/11/2018
More informationNCACH RAPID CYCLE APPLICATION: OPIOID PROJECT North Central Accountable Community of Health - Medicaid Transformation Project
NCACH RAPID CYCLE APPLICATION: OPIOID PROJECT North Central Accountable Community of Health - Introduction The North Central Accountable Community of Health (NCACH) is accepting applications from partners
More informationHealth Systems and Addiction: Provider Issues
Health Systems and Addiction: Provider Issues The Emerging Roles of Primary Care Patrick G. O Connor MD, MPH Dan and Amanda Adams Professor of General Medicine Chief, General Internal Medicine Yale University
More informationSTATES BEST PRACTICES IN IMPROVING STATE ORAL HEALTH PROGRAM WORKFORCE CAPACITY
STATES BEST PRACTICES IN IMPROVING STATE ORAL HEALTH PROGRAM WORKFORCE CAPACITY UCSF DPH 175 Dental Public Health Lecture Series January 26, 2016 Dr. Harry Goodman Immediate Past-President, Association
More informationJerry Cochran, MSW, PhD University of Utah School of Medicine Department of Internal Medicine Department of Psychiatry
Jerry Cochran, MSW, PhD University of Utah School of Medicine Department of Internal Medicine Department of Psychiatry Acknowledgements Funding for this work has come from: The Staunton Farm Foundation
More informationMedication Assisted Treatment for Opioid Use Disorders and Veteran Populations
Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations Kamala Greene Genece, Ph.D. VP, Clinical Director Phoenix Houses of New York Benjamin R. Nordstrom, M.D., Ph.D. President
More informationMainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders
Mainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders Alexander Y. Walley, MD, MSc Boston University School of Medicine ThINC Bergen 2015 Conference
More information